Literature DB >> 8557361

Antibody against the capsule of Vibrio cholerae O139 protects against experimental challenge.

D K Sengupta1, M Boesman-Finkelstein, R A Finkelstein.   

Abstract

Antiserum to the capsular polysaccharide of an opaque variant of Vibrio cholerae O139 strain MDO-12 recognizes capsular antigen in three different colonial variants of the strain, although the amount of recognition varies with the extent of opacity. The anti-capsular-polysaccharide serum, at subagglutinating doses, protected suckling mice against challenge with both the most opaque variant and the most translucent variant. Further studies indicated that the protection was associated with inhibition of intestinal colonization by the vibrios. These results thus highlight the potential importance of the capsule in immunoprophylaxis against cholera caused by V. cholerae O139.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557361      PMCID: PMC173765          DOI: 10.1128/iai.64.1.343-345.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.

Authors:  M M Levine; D R Nalin; J P Craig; D Hoover; E J Bergquist; D Waterman; H P Holley; R B Hornick; N P Pierce; J P Libonati
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

2.  Colonial recognition, a "new" approach for rapid diagnostic enteric bacteriology.

Authors:  R A Finkelstein; K Punyashthiti
Journal:  J Bacteriol       Date:  1967-06       Impact factor: 3.490

Review 3.  Vibrio cholerae O139 Bengal.

Authors:  M J Albert
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

4.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

5.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

Review 6.  Diseases of humans (other than cholera) caused by vibrios.

Authors:  P A Blake; R E Weaver; D G Hollis
Journal:  Annu Rev Microbiol       Date:  1980       Impact factor: 15.500

7.  Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype.

Authors:  T S Coster; K P Killeen; M K Waldor; D T Beattie; D R Spriggs; J R Kenner; A Trofa; J C Sadoff; J J Mekalanos; D N Taylor
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

8.  Preliminary structure determination of the capsular polysaccharide of Vibrio cholerae O139 Bengal Al1837.

Authors:  L M Preston; Q Xu; J A Johnson; A Joseph; D R Maneval; K Husain; G P Reddy; C A Bush; J G Morris
Journal:  J Bacteriol       Date:  1995-02       Impact factor: 3.490

9.  Intestinal distribution of Vibrio cholerae in orally infected infant mice: kinetics of recovery of radiolabel and viable cells.

Authors:  V S Baselski; C D Parker
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

10.  Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice.

Authors:  J A Johnson; P Panigrahi; J G Morris
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more
  6 in total

1.  Adherence of Vibrio cholerae to cultured differentiated human intestinal cells: an in vitro colonization model.

Authors:  J A Bénitez; R G Spelbrink; A Silva; T E Phillips; C M Stanley; M Boesman-Finkelstein; R A Finkelstein
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

2.  Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.

Authors:  G A Losonsky; Y Lim; P Motamedi; L E Comstock; J A Johnson; J G Morris; C O Tacket; J B Kaper; M M Levine
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

3.  Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid.

Authors:  A Boutonnier; S Villeneuve; F Nato; B Dassy; J M Fournier
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Genetic and phenotypic diversity of quorum-sensing systems in clinical and environmental isolates of Vibrio cholerae.

Authors:  Adam Joelsson; Zhi Liu; Jun Zhu
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

5.  Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice.

Authors:  Z Kossaczka; J Shiloach; V Johnson; D N Taylor; R A Finkelstein; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  A Self-Assembling Whole-Cell Vaccine Antigen Presentation Platform.

Authors:  Julie Liao; Daniel R Smith; Jóhanna Brynjarsdóttir; Paula I Watnick
Journal:  J Bacteriol       Date:  2018-07-10       Impact factor: 3.490

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.